Global Blood Platelets Market is valued at approximately USD 5.22 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.57% over the forecast period 2024-2032. Blood platelets, or thrombocytes, are small, disc-shaped cell fragments crucial for blood clotting and wound healing. Produced in the bone marrow, they circulate in the bloodstream and become activated when a blood vessel is injured. This activation triggers platelets to clump together, forming a plug that helps stop bleeding. Platelets also release growth factors essential for tissue repair and regeneration, making them vital in maintaining hemostasis and preventing excessive blood loss. Their significant role underscores their importance as a critical component of the circulatory system.
The Global Blood Platelets Market expansion is driven by the increasing prevalence of chronic and blood-related disorders worldwide, which elevates the demand for blood platelets. Additionally, the growing need for blood transfusions, heightened awareness regarding blood donations, and the rising number of surgical procedures further propel market growth. However, challenges such as the high risk of transmission of infections and the high cost of treatments are notable barriers to market expansion.
The key regions considered for the market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North American blood platelets market is anticipated to dominate the global landscape, attributable to factors such as the presence of major industry players, increasing demand for blood platelets, and advancements in novel technologies. Prominent entities such as America's Blood Centers, the American National Red Cross, and Blood Centers of America are actively engaged in adopting innovative technologies, fostering industrial expansion in the region. The high prevalence of chronic and blood diseases, coupled with rising hospital admissions, emphasizes the growing need for blood platelets in related medical procedures.
Major market players included in this report are:
Macopharma
Grifols, S.A.
Kawasumi Laboratories, Inc.
CSL Limited
Bio-Rad Laboratories, Inc.
Cerus Corporation
China Biologic Products Holdings, Inc.
Octapharma AG
B. Braun Melsungen AG
Haemonetics Corporation
The detailed segments and sub-segment of the market are explained below:
By Platelet Type
Whole Blood Derived Platelet
Apheresis Derived Platelets
By Application
Hemophilia
Thrombocytopenia
Perioperative Indications
Platelet Function Disorders
Hemato-oncology
Others
By End-use
Hospitals
Ambulatory Surgical Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market